TipRanks
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
US Market
BOLT
Bolt Biotherapeutics
RESEARCH TOOLSreports
Want to see BOLT full AI Analyst Report?

Bolt Biotherapeutics (BOLT) Stock News & Sentiment

250 Followers
Bolt Biotherapeutics Amends Lease, Reduces Facility Obligations
Premium
Company Announcements
Bolt Biotherapeutics Amends Lease, Reduces Facility Obligations
5d ago
8K
BOLT
BOLT Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
BOLT Upcoming Earnings Report: What to Expect?
2M ago
BOLT
Bolt Biotherapeutics Holds 2026 Annual Stockholder Meeting
Premium
Company Announcements
Bolt Biotherapeutics Holds 2026 Annual Stockholder Meeting
4M ago
8K
BOLT
Buy Rating on Bolt Biotherapeutics Driven by Differentiated Claudin 18.2 ISAC BDC-4182 and Solid Cash Runway to 2027
Premium
Ratings
Buy Rating on Bolt Biotherapeutics Driven by Differentiated Claudin 18.2 ISAC BDC-4182 and Solid Cash Runway to 2027
7M ago
BOLT
Buy Rating for Bolt Biotherapeutics: Innovative Approach and Strong Financials Drive Positive Outlook
Premium
Ratings
Buy Rating for Bolt Biotherapeutics: Innovative Approach and Strong Financials Drive Positive Outlook
11M ago
BOLT
Bolt Biotherapeutics Reports Improved Financial Performance
Premium
Company Announcements
Bolt Biotherapeutics Reports Improved Financial Performance
11M ago
BOLT
Bolt Biotherapeutics’ Pioneering Study on BDC-4182: A New Hope for Cancer Treatment
Premium
Company Announcements
Bolt Biotherapeutics’ Pioneering Study on BDC-4182: A New Hope for Cancer Treatment
12M ago
BOLT
More BOLT News >

BOLT News on the Web

Wall Street Analysts Are Neutral on Top Healthcare Picks
TipRanks News
Neutral
Bolt Biotherapeutics reports Q2 EPS ($4.57) vs. ($4.46) last year
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST), Revolution Medicines (RVMD) and Bolt Biotherapeutics (BOLT)
TipRanks News
Neutral
Bolt Biotherapeutics initiated with a Buy at Rodman & Renshaw
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Neutral
JonesTrading Keeps Their Hold Rating on Bolt Biotherapeutics (BOLT)
TipRanks News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Buy Rating on Bolt Biotherapeutics Driven by Differentiated Claudin 18.2 ISAC BDC-4182 and Solid Cash Runway to 2027
TipRanks News
Bullish

News Score - Last 7 Days

Negative
BOLT
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.25 articles
News Sentiment
This Week0%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BOLT’s Media Buzz Sentiment?
1 articles about BOLT were published this week. In an average week, 0.25 articles are published.
    What is BOLT’s weekly average amount of articles?
    In an average week, 0.25 articles about BOLT are published.
      What is BOLT’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      AMGNAmgen
      GKOSGlaukos
      OVIDOvid Therapeutics
      ABTAbbott Laboratories
      IQVIQVIA Holdings
      Showing the stocks with the most bullish news sentiment over the past week